152 related articles for article (PubMed ID: 16239206)
1. Oncogenic osteomalacia cured by removal of an organized hematoma.
Colt E; Gopan T; Chong HS
Endocr Pract; 2005; 11(3):190-3. PubMed ID: 16239206
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia. Evidence of a surgically correctable alteration in vitamin D metabolism.
Parker MS; Klein I; Haussler MR; Mintz DH
JAMA; 1981 Feb; 245(5):492-3. PubMed ID: 7452873
[TBL] [Abstract][Full Text] [Related]
3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive testing in the diagnosis of osteomalacia.
Bingham CT; Fitzpatrick LA
Am J Med; 1993 Nov; 95(5):519-23. PubMed ID: 7646591
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
7. [Oncogenic osteomalacia in a 49-year-old female patient].
Ludwig J; Mechtersheimer G; Haberkorn U; Nawroth P; Schilling T; Kasperk C
Dtsch Med Wochenschr; 2005 Feb; 130(5):206-9. PubMed ID: 15678388
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D metabolism in hypophosphatemic rickets.
Mason RS; Rohl PG; Lissner D; Posen S
Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced osteomalacia: clinical and basic studies.
Shane E; Parisien M; Henderson JE; Dempster DW; Feldman F; Hardy MA; Tohme JF; Karaplis AC; Clemens TL
J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
[TBL] [Abstract][Full Text] [Related]
11. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
Ryan WG; Gitelis S; Charters JR
Calcif Tissue Int; 1986 Jun; 38(6):358-62. PubMed ID: 3089559
[TBL] [Abstract][Full Text] [Related]
12. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia.
Reis-Filho JS; Paiva ME; Lopes JM
Brain Pathol; 2004 Jan; 14(1):111-2, 115. PubMed ID: 14997944
[TBL] [Abstract][Full Text] [Related]
13. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia.
Takemia T; Sato K; Miyata M; Imaki T; Shibasaki T; Tsushima T; Demura H; Tanaka R; Obara T; Oguchi S
Endocr J; 1993 Feb; 40(1):121-6. PubMed ID: 7951485
[TBL] [Abstract][Full Text] [Related]
14. Cinacalcet in the management of tumor-induced osteomalacia.
Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
[TBL] [Abstract][Full Text] [Related]
15. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
Epstein S; Meunier PJ; Lambert PW; Stern PH; Bell NH
Acta Endocrinol (Copenh); 1983 Jun; 103(2):241-7. PubMed ID: 6687971
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced osteomalacia.
Schapira D; Ben Izhak O; Nachtigal A; Burstein A; Shalom RB; Shagrawi I; Best LA
Semin Arthritis Rheum; 1995 Aug; 25(1):35-46. PubMed ID: 8525389
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic vitamin D resistant hypophosphatemic osteomalacia (benign ossifying mesenchymal tumor of bone): case report.
Uchida H; Yokoyama S; Kashima K; Nakayama I; Shimizu K; Masumi S
Jpn J Clin Oncol; 1991 Jun; 21(3):218-26. PubMed ID: 1942553
[TBL] [Abstract][Full Text] [Related]
18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
19. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
20. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
